Zacks Investment Research
07 Aug 2026, 03:36 UTC · 2h ago
Profound Medical (PROF) Q2 Earnings Surpass Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 03:36 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Profound Medical reported quarterly earnings of $0.26 per share, significantly beating the Zacks Consensus Estimate of a $0.22 loss. — A swing from a projected loss to a positive profit represents a substantial earnings surprise of 218.18%.
+0.60Profound Medical's quarterly revenues of $2.48 million missed the Zacks Consensus Estimate by 55.66%. — A significant revenue miss suggests weakness in top-line growth or commercial execution despite the earnings beat.
-0.40Which stocks this story touches
The company reported a significant earnings beat with a surprise of 218.18%, although it missed revenue estimates.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
1h ago
